Adicet Bio Inc (ACET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -116,803 | -117,122 | -142,658 | -69,790 | -61,999 |
| Depreciation Amortization | 2,331 | 4,839 | 25,590 | 2,667 | 1,723 |
| Accounts receivable | N/A | N/A | N/A | N/A | -30 |
| Accounts payable and accrued liabilities | 1,029 | 1,106 | -1,683 | 1,710 | 1,137 |
| Other Working Capital | 1,473 | -5,525 | 252 | 2,744 | -6,057 |
| Other Operating Activity | 16,724 | 24,324 | 24,782 | 17,904 | 14,174 |
| Operating Cash Flow | $-95,246 | $-92,378 | $-93,717 | $-44,765 | $-51,052 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,131 | -118,124 | N/A | N/A | 10,250 |
| PPE Investments | -1,738 | -1,118 | -4,464 | -16,782 | -13,046 |
| Investing Cash Flow | $2,393 | $-119,242 | $-4,464 | $-16,782 | $-2,796 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 75,499 | 111,448 | 386 | 45,107 | 242,946 |
| Other Financing Activity | -254 | -141 | -150 | -3,598 | -261 |
| Financing Cash Flow | $75,245 | $111,307 | $236 | $41,509 | $242,685 |
| Beginning Cash Position | 59,398 | 159,711 | 257,656 | 277,694 | 88,857 |
| End Cash Position | 41,790 | 59,398 | 159,711 | 257,656 | 277,694 |
| Net Cash Flow | $-17,608 | $-100,313 | $-97,945 | $-20,038 | $188,837 |
| Free Cash Flow | |||||
| Operating Cash Flow | -95,246 | -92,378 | -93,717 | -44,765 | -51,052 |
| Capital Expenditure | -1,738 | -1,118 | -4,464 | -16,782 | -13,046 |
| Free Cash Flow | -96,984 | -93,496 | -98,181 | -61,547 | -64,098 |